SNCA and multiple sclerosis: The drug’s neuroprotective effects are particularly notable in Parkinson’s disease, where it influences α-synuclein aggregation and clearance, and in multiple sclerosis, where it modulates neuroinflammation and immune responses [260,261,277,278].